Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial-Reference-Cited by-同舟云学术

Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial

Published:2015-12 Issue:3 Volume:117 Page:432-437
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Fokas Emmanouil,Clifford Charlotte,Spezi Emiliano,Joseph George,Branagan Jennifer,Hurt Chris,Nixon Lisette,Abrams Ross,Staffurth John,Mukherjee Somnath

Funder

NIHR Biomedical Research, Oxford

CRUK

Kidani Memorial Trust

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference17 articles.

1. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704–a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas;Abrams;Int J Radiat Oncol Biol Phys,2012

2. Patient selection and radiotherapy volume definition - can we improve the weakest links in the treatment chain?;Roques;Clin Oncol,2014

3. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02;Peters;J Clin Oncol,2010